Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1 dose escalation study to determine the safety, tolerability,
pharmacokinetics, pharmacodynamics and preliminary anti-tumor activity of BMS-754807 in
patients with advanced or metastatic solid tumors. In addition, the study is expected to
identify the recommended dose or dose range of BMS-754807 for Phase 2 studies